Upon treatment with either CDK4/6 inhibitor alone, or in combination with RA, ICC showed an increase in TUBB3 expression and neurite extension (compared to DMSO or RA treatment) (Figure 2C). Here, CDK4 is linked to intrahepatic cholangiocarcinoma.